DIASORIN

DIASORIN

DiaSorin develops, produces and commercializes diagnostic tests for a wide range of clinical areas. The company’s tests are designed for hospital and private testing laboratories in the markets of immunodiagnostics and molecular diagnostics.
Products Covid-19
Close

Covid-19 DIASORIN

Clinical Laboratory

SARS-CoV-2 Ag Assay
LIAISON SARS-CoV-2 Ag

The LIAISON SARS-CoV-2 Ag assay is a chemiluminescence sandwich-immunoassay (CLIA) based technology for the quantitative determination of Nucleocapsid antigen protein from SARS-CoV-2 samples - in nasal swab (NS), nasopharyngeal swab (NPS) eluted in UTM/VTM directly from individuals who are suspected of COVID-19 by their healthcare provider within the first 10 days of the onset of symptoms. The assay is a unique quantitative solution to detect suspected COVID-19 patients, do contact tracing and rapidly implement isolation procedures for those patients who have been infected and might be able to spread SARS-CoV-2.
More details

SARS-CoV-2 IgM Assay
LIAISON SARS-CoV-2 IgM

The LIAISON SARS-CoV-2 IgM is a fully automated assay to be run on LIAISON X for detecting IgM antibody to the SARS-CoV-2 virus that causes COVID-19. The assay offers high sensitivity and specificity to ensure accurate results along the infection window.
More details

SARS-CoV-2 TrimericS IgG Assay
LIAISON SARS-CoV-2 TrimericS IgG Assay

The LIAISON SARS-CoV-2 TrimericS IgG Assay is a new generation of chemiluminescence immunoassay (CLIA), for the quantitative determination of anti-trimeric spike protein specific IgG antibodies to SARS-CoV-2 in human serum or plasma samples. The assay is intended as an aid in the diagnosis of CoVID-19 and to support the study of the immune status of infected patients by providing an indication of the presence of neutralizing IgG antibodies against SARS-CoV-2.
More details

SARS-CoV-2 S1/S2 IgG Assay
LIAISON SARS-CoV-2 S1/S2 IgG

The LIAISON SARS-CoV-2 S1/S2 IgG is a quantitative assay for the detection of IgG antibodies against S1/S2 antigens of SARS-CoV-2. The fully automated solution with a throughput of up to 170 results/hour on LIAISON XL has high sensitivity and specificity to ensure accurate results. The quantitative assay with correlation to neutralizing antibodies can be used as an upstream pre-screening tool.
More details

Recently updated

Anti-Thyroid Peroxidase Assay
LIAISON Anti-TPO

LIAISON Anti-TPO is an automated CLIA assay for the quantitative determination of autoantibodies against thyroid peroxidase (TPO) in human serum or plasma. It serves as an aid in diagnosing autoimmune thyroid disorders, especially during pregnancy and post-delivery in patients with thyroiditis. The assay provides accurate and rapid results, supporting clinical decision-making in thyroid health management.
More details

HSV Infection Test
LIAISON Herpes Simplex Virus Diagnostic Solution

The LIAISON Herpes Simplex Virus Diagnostic Solution offers an automated panel to aid in the differential diagnosis of HSV infections. It is designed to assist clinicians in assessing infection risk, especially during pregnancy. This complete diagnostic solution ensures accurate identification of herpes simplex virus, supporting clinical decision-making in both routine and high-risk cases.
More details

MR-proADM Assay
LIAISON BRAHMS MR-proADM

The LIAISON BRAHMS MR-proADM is a quantitative CLIA assay that measures Mid-regional pro-adrenomedullin (MR-proADM) levels to assess disease severity and prognosis in patients with suspected infections. This solution helps emergency departments prioritize critically ill patients for timely decision-making. With results in just 35 minutes, it ensures efficient patient disposition, enhancing emergency care workflows and clinical outcomes.
More details

Clinical Laboratory

Anti-Thyroid Peroxidase Assay
LIAISON Anti-TPO

LIAISON Anti-TPO is an automated CLIA assay for the quantitative determination of autoantibodies against thyroid peroxidase (TPO) in human serum or plasma. It serves as an aid in diagnosing autoimmune thyroid disorders, especially during pregnancy and post-delivery in patients with thyroiditis. The assay provides accurate and rapid results, supporting clinical decision-making in thyroid health management.
More details

HSV Infection Test
LIAISON Herpes Simplex Virus Diagnostic Solution

The LIAISON Herpes Simplex Virus Diagnostic Solution offers an automated panel to aid in the differential diagnosis of HSV infections. It is designed to assist clinicians in assessing infection risk, especially during pregnancy. This complete diagnostic solution ensures accurate identification of herpes simplex virus, supporting clinical decision-making in both routine and high-risk cases.
More details

MR-proADM Assay
LIAISON BRAHMS MR-proADM

The LIAISON BRAHMS MR-proADM is a quantitative CLIA assay that measures Mid-regional pro-adrenomedullin (MR-proADM) levels to assess disease severity and prognosis in patients with suspected infections. This solution helps emergency departments prioritize critically ill patients for timely decision-making. With results in just 35 minutes, it ensures efficient patient disposition, enhancing emergency care workflows and clinical outcomes.
More details

Chlamydia Trachomatis Test
LIAISON Chlamydia Trachomatis Diagnostic Solution

The LIAISON Chlamydia Trachomatis Diagnostic Solution provides a fully automated serological testing for the rapid detection of Chlamydia trachomatis infection. Using CLIA assays, it detects specific IgA and IgG antibodies in human serum or plasma. IgA antibody detection is indicative of active infection, while IgG antibodies suggest past or chronic infection. This solution is ideal for clinical settings, offering fast results for diagnosis and post-therapy follow-up.
More details

Varicella Zoster Virus Assay
LIAISON VZV Assay Panel (IgG HT, IgM)

The LIAISON VZV Assay Panel (IgG HT, IgM) is an advanced chemiluminescent immunoassay (CLIA) designed for the qualitative and quantitative detection of Varicella Zoster Virus (VZV) antibodies (IgG and IgM) in human serum or plasma. Automated on the LIAISON® platform, this panel ensures high sensitivity, specificity, and consistency—delivering accurate, reproducible results for reliable serological evaluation.
More details

Chagas Disease Test
LIAISON Chagas

The LIAISON Chagas CLIA is an automated CLIA assay for the qualitative determination of antibodies to Tripanosoma cruzi in human serum and plasma samples including specimens collected post-mortem. It offers high specificity with minimal cross-reactivity to diseases like malaria and leishmaniasis. Ideal for screening organ donors or at-risk populations, the automated format supports high-throughput and consistent Chagas disease diagnostics.
More details

Lyme Disease Test
LIAISON LymeDetect

LIAISON LymeDetect is an innovative approach to EARLY Lyme disease diagnosis that combines assays measuring B cell humoral immunity, LIAISON IgG and IgM CLIA assays, and T cell mediated immunity with the patented QuantiFERON IGRA technology. It supports early diagnosis of Lyme disease for treatment of patients before severe illness develops.
More details

Pneumococcal Pneumonia/Legionella Test
LIAISON Urinary Ag Tests

The LIAISON CLIA Urinary Ag solution quickly, accurately and automatically identifies S. pneumoniae and L. pneumophila antigens in urinary specimens of adult patients with suspected pneumonia. The automatic interpretation of test results allows healthcare professionals to rapidly distinguish between pneumococcal pneumonia and Legionella infection.
More details

Zika Virus Test
LIAISON XL Zika Capture IgM II

LIAISON XL Zika Capture IgM II is a fully automated solution for specific and accurate diagnosis of acute Zika or a recent virus infection with the qualitative determination of Zika Virus IgM antibodies in human serum. Using an innovative assay format utilizing the Zika NS1 antigen, the LIAISON® XL Zika Capture IgM II assay has limited cross reactivity to other common flaviviruses such as Dengue and West Nile Virus.
More details

Mumps Test
LIAISON® Mumps Panel (IgG, IgM)

The LIAISON® Mumps panel (IgG, IgM) is a CLIA-based automated solution for diagnosing mumps virus infections and assessing immune status. It assists in differential diagnosis, particularly in immunized or high-risk individuals. This reliable and efficient test supports clinicians in preventing and managing mumps outbreaks.
More details

Legionella Assay
LIAISON® Legionella Urinary Ag

The LIAISON® Legionella Urinary Ag test is an automated CLIA-based immunoassay for detecting Legionella antigens in urine. It supports the early diagnosis of Legionella-induced pneumonia, a leading cause of community-acquired pneumonia (CAP). With high sensitivity and automation, it aids in targeted antibiotic therapy, improving patient management.
More details

Treponema Pallidum Assay
LIAISON® Treponema Screen

The LIAISON® Treponema Screen is an automated chemiluminescent immunoassay (CLIA) for detecting Treponema pallidum antibodies in serum and plasma. This highly sensitive test is used for syphilis screening and post-mortem analysis. Designed for rapid and automated processing, it enhances diagnostic efficiency in clinical and laboratory settings.
More details

Streptococcus Pneumoniae Test
LIAISON® S. pneumoniae Ag

LIAISON® S. pneumoniae Ag detects Streptococcus pneumoniae antigen in urine samples, covering 91 serotypes. This automated CLIA-based test delivers standardized results in under an hour, aiding in pneumonia diagnosis. By enabling pathogen-directed therapy, it reduces broad-spectrum antibiotic use. Compatible with LIAISON® XL and XS analyzers, this test improves diagnostic precision, workflow efficiency, and patient outcomes in suspected pneumococcal pneumonia cases.
More details

Endocrinology Test
LIAISON Growth Hormone Disorders Diagnostic Solution

The LIAISON Growth Hormones Disorder Solutions include the LIAISON hGH assay which uses chemiluminescent immunoassay (CLIA) technology for the in vitro quantitative determination of human growth hormone in human serum specimens. It also includes the LIAISON IGF-I kit which uses CLIA technology for the quantitative determination of the insulin-like growth factor (somatomedin C or Sm-C, IGF-1) in human serum.
More details

Elastase-1 Test
LIAISON Elastase-1

The LIAISON Elastase-1 test is a diagnostic tool used to measure elastase-1 levels in stool samples, helping to evaluate pancreatic exocrine function. This test aids in diagnosing conditions like chronic pancreatitis and pancreatic insufficiency, providing reliable and precise results to assist clinicians in managing gastrointestinal diseases effectively.
More details

Tissue Transglutaminase (tTG) Assay
LIAISON TTG IgA

The LIAISON TTG IgA test is designed to detect IgA antibodies to tissue transglutaminase (tTG) in human serum. It is primarily used for the diagnosis of celiac disease, providing accurate results with high sensitivity and specificity. This test enhances clinical decision-making by facilitating early detection of gluten-related disorders.
More details

Free Human Prostate-Specific Antigen CLIA
LIAISON fPSA

LIAISON fPSA is an automated CLIA assay for the quantitative determination of free human prostate-specific antigen (fPSA) in human serum and plasma (EDTA or heparinized). The combined use of free PSA and total PSA is an aid in the discrimination of benign and malignant diseases with increased specificity of early detection of prostate cancer.
More details

Carcinoembryonic Antigen CLIA
LIAISON CEA

LIAISON CEA is an automated CLIA assay for the quantitative determination of carcinoembryonic antigen (CEA) in human serum as well as in EDTA or heparinized human plasma. The test can be used as an aid during the follow-up of cancer patients.
More details

Thymidine Kinase CLIA
LIAISON Thymidine Kinase

LIAISON Thymidine Kinase is an automated CLIA assay for the quantitative determination of Thymidine Kinase (TK) activity in human serum or EDTA plasma. The assay results should be used in conjunction with other clinical and laboratory data to assist in the diagnosis and management of conditions involving hematologic malignancies.
More details

Prostate-Specific Antigen CLIA
LIAISON PSA

LIAISON PSA is an automated CLIA assay for the quantitative determination of human prostate-specific antigen (PSA) in human serum and plasma (heparinized, EDTA). The combined use of free PSA and total PSA is used as an aid in the discrimination of benign and malignant disease with increased specificity of early detection of prostate cancer.
More details

Metabolic Disorder Test
LIAISON Bone & Mineral Diagnostic Solution

LIAISON Bone & Mineral Diagnostic Solution is intended for the detection of 1 - 84 PTH, N-TACT PTH, BAP OSTASE, OSTEOCALCIN, FGF 23. The test can aid in assessing the calcium and phosphorus metabolic status to provide a clinical picture of the patient with CKD, hyperparathyroidism and hypoparathyroidism, or other calcium metabolism disorders.
More details

Endocrinology Test
LIAISON® C-Peptide

The LIAISON® C-Peptide is a highly accurate CLIA assay for the accurate measurement of the level of C-peptide in a blood sample. The test can provide important information to help understand, monitor, and/or treat disorders that involve how well the body makes insulin, such as hypoglycemia (low blood sugar) and diabetes.
More details

Tumor Marker
LIAISON CA 125II

The LIAISON CA 125II is an automated CLIA assay for the quantitative determination of CA 125 antigen in human serum as well as in EDTA or heparinized human plasma. The test can be used as an aid during the follow-up of patients with primary invasive ovarian carcinoma.
More details

Tumor Marker
LIAISON B2-Microglobulin

The LIAISON B2-Microglobulin is an automated CLIA assay for the quantitative determination of β2-microglobulin (B2M) in human serum, plasma, and urine. This test can be used as an aid in the diagnosis of active rheumatoid arthritis and kidney disease, as well as in the evaluation of the severity and prognosis of certain cancers including multiple myeloma and some lymphomas.
More details

Respiratory Assay
LIAISON PLEX Respiratory Flex Assay

LIAISON PLEX Respiratory Flex Assay is a multiplexed qualitative molecular test for the simultaneous detection and identification of up to 19 bacterial and viral targets, including SARS-CoV-2. The automated, multiplex PCR assay runs on the LIAISON PLEX® System to detect up to 5 bacterial and 14 viral pathogens, including the most relevant pathogen today—SARS-CoV-2—in one sample.
More details

Alpha-Fetoprotein CLIA
LIAISON AFP

The LIAISON AFP is an automated CLIA assay for the quantitative determination of alpha-fetoprotein (AFP) in human serum as well as in EDTA and heparinized human plasma or amniotic fluid. The test can be used as an aid for pregnancy monitoring and as an aid during the follow-up of tumor patients.
More details

Campylobacter Ag CLIA
LIAISON Campylobacter Ag

The LIAISON Campylobacter Ag is an automated CLIA assay for the qualitative determination of Campylobacter antigens in human stool specimens. The determination of Campylobacter is an aid in the diagnosis of gastrointestinal disorders.
More details

C. difficile CLIA
LIAISON C. difficile Diagnostic Solution

The LIAISON C. difficile Diagnostic Solution is an automated CLIA assay for the detection of Clostridium Difficile GDH antigen, glutamate dehydrogenase, in human feces. It offers a one-stop solution with the same CLIA technology for the determination of C. difficile infections using the same stool sample.
More details

Bordetella pertussis Toxin CLIA
LIAISON Bordetella pertussis Toxin IgA

The LIAISON Bordetella pertussis Toxin IgA is an automated CLIA assay for the quantitative determination of IgA antibodies to Bordetella pertussis toxin in human serum and plasma samples. The detection of Bordetella pertussis toxin IgG and IgA is needed to differentiate between recent Bordetella pertussis infection and late stage of the disease, especially in older children and adults, and to aid clinical decisions.
More details

H. pylori Test
LIAISON H. pylori Diagnostic Solution

The LIAISON H. pylori Diagnostic Solution comprises LIAISON Meridian H. pylori SA and LIAISONH. pylori IgG tests for patients suspected of having H. pylori infection and measuring post-therapy response. The assay provides a simple alternative to the urea breath test and provides rapid results in 30 minutes, allowing doctors to immediately start appropriate treatment.
More details

S-100B Protein Test
LIAISON S100

LIAISON S100 is an automated CLIA assay for the determination of protein S-100B in human serum and CSF (cerebrospinal fluid). The test can be used as an aid in the diagnosis of malignant melanoma and as an aid in the diagnosis and prognosis of traumatic brain injury.
More details

Tissue Polypeptide Antigen Test
LIAISON TPA-M

The LIAISON TPA-M is an automated CLIA assay for the quantitative determination of tissue polypeptide antigen (TPA) in human serum. The test can be used as an aid in the diagnosis of patients with carcinomas such as lung cancer, breast cancer, bladder cancer, and therapy monitoring after tumor surgery or treatment.
More details

Hepatitis B Virus Test
LIAISON HAV IgM Assay

The LIAISON HAV IgM assay uses chemiluminescent immunoassay (CLIA) technology for the qualitative determination of IgM immunoglobulin to hepatitis A virus (IgM anti-HAV) in human serum or plasma samples. The test has to be performed on the LIAISON analyzer family.
More details

Measles Virus Antibody Test
LIAISON Measles IgM Assay

The LIAISON Measles IgM assay uses chemiluminescence immunoassay (CLIA) technology for the qualitative determination of specific IgM antibodies to measles virus in human serum or plasma samples. It is intended to be used as an aid in the determination of serological status to measles virus and has to be performed on the LIAISON analyzer.
More details

Rubella Virus Antibody Test
LIAISON Rubella IgG Assay

The LIAISON Rubella IgG assay uses chemiluminescence immunoassay (CLIA) technology for the quantitative determination of specific IgG antibodies to rubella virus in human serum or plasma samples. Designed to be performed on the LIAISON analyzer family, the sensitive assay is able to detect low IgG antibody titers present in vaccinated population, reducing the number of samples to be confirmed.
More details

Thyroglobulin (Tg) Assay
LIAISON Anti-Tg

LIAISON Anti-Tg is an in vitro assay for the quantitative determination of autoantibodies against thyroglobulin (Tg) in human serum as well as in EDTA and heparinised human plasma. The test has to be performed on the LIAISON Analyzer which is capable of running 94 patient samples at the same time.
More details

Rotavirus Assay
LIAISON Rotavirus

The DiaSorin LIAISON Rotavirus assay is an in vitro diagnostic chemiluminescent immunoassay (CLIA) intended for the qualitative determination of rotavirus antigen in human stool specimens and must be performed on the LIAISON Analyzer. The test is used primarily as an aid for the diagnosis of acute viral gastroenteritis and the results are to be used in conjunction with information obtained from the patients’ clinical evaluation and other diagnostic procedures.
More details

1-84 PTH Chemiluminescent Immunoassay
LIAISON 1-84 PTH Assay

The LIAISON 1-84 PTH assay is a chemiluminescent immunoassay (CLIA) intended for the quantitative determination of 1-84 PTH without cross-reaction to 7-84 PTH fragment in human serum and EDTA plasma. Measurements of parathyroid hormone levels are used in the differential diagnosis of hypercalcemia and hypocalcemia resulting from disorders of phosphorus and calcium metabolism. The test has to be performed on the LIAISON Analyzer which is capable of running 94 patient samples at the same time.
More details

M. Tuberculosis Indirect Test
LIAISON QuantiFERON-TB Gold Plus

The LIAISON QuantiFERON-TB Gold Plus assay is an in vitro diagnostic test for the detection of interferon-y (IFN-y) in human lithium heparin plasma by chemiluminescence immunoassay (CUA) using the LIAISON XL Analyzer. The assay is a qualitative indirect test for M. tuberculosis infection (including disease) and is intended for use in conjunction with risk assessment, radiography, and other medical and diagnostic evaluations to assist the clinician in making individual patient management decisions.
More details

Procalcitonin Chemiluminescence Immunoassay
LIAISON BRAHMS PCT II GEN

LIAISON BRAHMS PCT II GEN assay uses chemiluminescence immunoassay (CLIA) technology for the in vitro quantitative determination of Procalcitonin in human serum and plasma specimens. The assay is intended for use, in conjunction with other laboratory findings and clinical assessments, to aid in the risk analysis of critically ill patients for progression of relevant bacterial infections.
More details

Tuberculosis Molecular Test
LIAISON QuantiFERON -TB Gold Plus

The LIAISON QuantiFERON -TB Gold Plus, developed in partnership with QIAGEN, is an in vitro diagnostic test for the detection of interferon-y (IFN-y) in human lithium heparin plasma by chemiluminescence immunoassay (CUA) using the LIAISON XL Analyzer. The assay is a qualitative indirect test for M. tuberculosis infection (including disease) and is intended for use in conjunction with risk assessment, radiography, and other medical and diagnostic evaluations to assist the clinician in making individual patient management decisions.
More details

Bacterial/Viral Infection Blood Test
LIAISON MeMed BV

The LIAISON MeMed BV test is the first fully automated solution, which utilizes host response-based data to enable physicians to differentiate accurately between bacterial and viral infections, supporting fast and better-informed treatment and patient management decisions. From a simple serological sample, it automatically measures, analyzes and integrates the levels of three host immune proteins into a single and simple score, showing the likelihood of a bacterial immune response or co-infection versus a likely viral immune response. The high-throughput, high-quality chemiluminescent assay easily identifies the source of a patient’s infection using the LIAISON XL automatic analyzer.
More details

SARS-CoV-2 S1/S2 IgG Assay
LIAISON SARS-CoV-2 S1/S2 IgG

The LIAISON SARS-CoV-2 S1/S2 IgG is a quantitative assay for the detection of IgG antibodies against S1/S2 antigens of SARS-CoV-2. The fully automated solution with a throughput of up to 170 results/hour on LIAISON XL has high sensitivity and specificity to ensure accurate results. The quantitative assay with correlation to neutralizing antibodies can be used as an upstream pre-screening tool.
More details

SARS-CoV-2 TrimericS IgG Assay
LIAISON SARS-CoV-2 TrimericS IgG Assay

The LIAISON SARS-CoV-2 TrimericS IgG Assay is a new generation of chemiluminescence immunoassay (CLIA), for the quantitative determination of anti-trimeric spike protein specific IgG antibodies to SARS-CoV-2 in human serum or plasma samples. The assay is intended as an aid in the diagnosis of CoVID-19 and to support the study of the immune status of infected patients by providing an indication of the presence of neutralizing IgG antibodies against SARS-CoV-2.
More details

SARS-CoV-2 IgM Assay
LIAISON SARS-CoV-2 IgM

The LIAISON SARS-CoV-2 IgM is a fully automated assay to be run on LIAISON X for detecting IgM antibody to the SARS-CoV-2 virus that causes COVID-19. The assay offers high sensitivity and specificity to ensure accurate results along the infection window.
More details

SARS-CoV-2 Ag Assay
LIAISON SARS-CoV-2 Ag

The LIAISON SARS-CoV-2 Ag assay is a chemiluminescence sandwich-immunoassay (CLIA) based technology for the quantitative determination of Nucleocapsid antigen protein from SARS-CoV-2 samples - in nasal swab (NS), nasopharyngeal swab (NPS) eluted in UTM/VTM directly from individuals who are suspected of COVID-19 by their healthcare provider within the first 10 days of the onset of symptoms. The assay is a unique quantitative solution to detect suspected COVID-19 patients, do contact tracing and rapidly implement isolation procedures for those patients who have been infected and might be able to spread SARS-CoV-2.
More details

Hepatitis D Assay
LIAISON XL Anti-HDV

The LIAISON XL Anti-HDV assay uses chemiluminescence immunoassay (CLIA) technology for the qualitative detection of total antibodies to hepatitis D virus in human serum and plasma samples. The assay results, in conjunction with other laboratory results and clinical information, are intended to be used as an aid in the diagnosis of HDV infection and as a screening test for organ and tissue donors.
More details

Calprotectin Test
LIAISON Calprotectin Test

The LIAISON Calprotectin test provides fast, reliable and automated detection of calprotectin in feces that is a marker used to help differentiate IBS (Irritable Bowel Syndrome) from IBD (Inflammatory Bowel Disease) and assess disease activity in IBD. Calprotectin is a heterocomplex composed of the calcium and zinc binding proteins S100A8 and S100A9, is resistant to enzymatic degradation, and can be easily measured in feces, making it ideal for direct detection by immunochemistry methods.
More details

Tuberclosis Assay
LIAISON QuantiFERON-TB Gold Plus

The LIAISON QuantiFERON-TB Gold Plus is a fully automated CLIA assay to aid in the diagnosis of TB infection and can detect both active and latent TB infection. It is designed to work with QIAGEN Quantiferon-TB Gold Plus Blood Collection Tubes which employ TB-specific antigens that elicit both CD8+ and CD4+ T cell responses for accurate assessment of cell-mediated immune response to TB infection.
More details

CLIA Analyzer
LIAISON XS

The LIAISON XS is a fully-automated CLIA analyzer with an efficient design and reduced dimensions that helps achieve higher efficiency and effectively perform low volume specialties and routine tests. It offers a new level of reliability and higher performance in results quality and workflow efficiency and optimization.
More details

ELISA Reader
ELx800

The ELx800 ELISA reader has a compact footprint and proven robust design that makes it an ideal solution for several microplate-based biological assays. Available in 6-, 12-, 24-, 48-, 96- and 384-well capability to meet a variety of assay needs, it is designed for applications within the clinical, biotechnology research and pharmaceutical laboratory.
More details

CLIA Analyzer
LIAISON

The LIAISON CLIA analyzer combines a flexible operating module with a broad menu of assays, resulting in high efficiency due to its lengthy walk-away time. It offers the possibility to run up to 15 different assays at a time, providing rational everyday testing even with a small number of samples.
More details

Zika Virus IgM Assay
LIAISON XL Zika Capture IgM

The LIAISON XL Zika Capture IgM is a first-of-its-kind assay for Zika virus IgM detection that yields results in as little as 51 minutes. The capture assay and the use of recombinant specific antigen assure superior specificity without cross reactions with other Arboviruses.
More details

ELISA Analyzer
Freedom EVOlyzer

The Freedom EVOlyzer is a dedicated platform for the automation of microplate¬based chromogenic ELISAs, and can be easily adapted to meet the changing workflow and throughput requirements of today’s diagnostic laboratory. Controlled by the easy-to-use Freedom EVOlution software, the platform offers outstanding flexibility for a wide variety of ELISA protocols and is designed to reduce hands-on time for ELISA processing.
More details

Chemiluminescence Analyzer
LIAISON XL

The LIAISON XL is a fully automated chemiluminescence analyzer, performing complete sample processing (sample pre-dilutions, sample and reagent dispensing, incubations, wash processes, etc.) as well as measurement and evaluation. It adopts the “Flash” chemiluminescence technology (CLIA) with paramagnetic microparticle solid phase and optimizes throughput by splitting the pipetting phases of reagents and samples into different cycles.
More details

Microtiter Plate Analyzer
ETI-Max 3000

The ETI-Max 3000 is a fully automated microtiter plate analyzer that performs the complete sample processing (sample pre-dilutions, sample and reagent dispensing, incubations, wash processes, plate transports) as well as photometric measurement and evaluation. The instrument is controlled by Windows PC software which allows the user to process pre-defined assays as well as assays programmed by the user.
More details
Copyright © 2000-2025 TradeMed.com. All rights reserved. | Terms And Conditions